The global immunofluorescence assay (IFA) market size is expected to reach USD 4.01 billion by 2028 at a CAGR of 6.3%, according to the latest report by Reports and Data. Increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector are key factors expected to drive market revenue growth over the forecast period.

Read More:https://www.reportsanddata.com..../report-detail/immun

image